Jin Yang, PhD

Associate Director, Market Access and Outcomes Strategy


PhD, Biochemistry and Molecular Biology
MS, Biochemistry and Molecular Biology
University of Rochester, Rochester, NY

BS, Biology and Biotechnology
State University of New York at Oneonta, Oneonta, NY

Jin Yang, PhD, is an Associate Director in the Market Access and Outcomes Strategy group at RTI-HS. She has more than 12 years of experience working in medical communications and has received training in regulatory affairs in drug development and medical devices. Prior to joining RTI-HS, she was a medical and scientific writer and editor for a professional writing company serving pharmaceutical, biotech, and medical device industries. She has been formally trained in the conduct of Cochrane systematic literature reviews and has conducted numerous literature reviews and has been a major technical contributor in developing product value messages, global value dossiers, and Academy of Managed Care Pharmacy dossiers, health economics and outcomes research (HEOR) evidence plan, as well as data curation. In addition, she is experienced in preparing manuscripts, scientific posters, Microsoft PowerPoint presentations, and various computer-based and print-based clinical materials. Dr. Yang has worked in a variety of therapeutic areas, including oncology, autoimmune diseases, cardiovascular diseases, neurology, dermatology, diabetes and endocrine disorders, gastroenterology, infectious disease, medical devices, metabolic diseases, ophthalmology, pain, psychiatry, respiratory, rheumatology, and women's health.

Send Jin Yang a message

Each document must be under 2 MB.
Maximum 3 files.
2 MB limit.
Allowed types: pdf, doc, docx, xls, xlsx, txt.

By submitting this form, you accept the RTI-HS privacy policy.